Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01134913 · ClinicalTrials.gov registry record
Multi-Markers In the Diagnosis of Acute Coronary Syndrome
A clinical trial, sponsored by Abbott RDx Cardiometabolic.
- Completed
- Registry status
- 621
- Enrollment target
NCT01134913 is a clinical trial that has completed, run by Abbott RDx Cardiometabolic. The registered enrollment target is 621 participants.
The verdict
NCT01134913 has completed, sponsored by Abbott RDx Cardiometabolic.
- COMPLETED
- Registry status
- 621 participants
- Enrollment target
Study Summary
This is a prospective clinical study designed to procure blood samples from patients who present to the Emergency Department with suspected ACS (Acute Coronary Syndrome). Subjects enrolled in this study will sign and informed consent and have 4 blood samples drawn at different time points during their emergency department visit. In addition, data will be collected about the patient's health history, hospital procedures, and final diagnosis. The enrolling center will also contact the patients at 30-days, 3 months and 6 months to inquire about their condition and survival. Blood samples collected in this study will be sent to the sponsor organization for long-term storage and analysis in the future for novel blood markers as they become available. No genetic testing will be conducted on these samples.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 621 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01134913
The ClinicalTrials.gov registry entry for NCT01134913 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 621 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott RDx Cardiometabolic, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01134913 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01134913 about?
NCT01134913 is a clinical study titled "Multi-Markers In the Diagnosis of Acute Coronary Syndrome". This is a prospective clinical study designed to procure blood samples from patients who present to the Emergency Department with suspected ACS (Acute Coronary Syndrome). Subjects enrolled in this study will sign and informed consent and have 4 blood samples drawn at different time points during th...
What is the current status of trial NCT01134913?
This trial is currently completed. The enrollment target is 621 participants. The study started on 2010-03. Estimated completion is 2011-12.
Who is sponsoring clinical trial NCT01134913?
This trial is sponsored by Abbott RDx Cardiometabolic, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.